YUKON, OKLAHOMA —For more than a decade now, Tekton Research has never wavered from its focus of operating successful clinical trials across a network of clinical research locations throughout the United States. Tekton continues to grow, partnering with experienced research physicians, to pursue an investigative passion to uncover new information that may lead to discovering medical breakthroughs.
Dr. Arambula, a respected board-certified pediatrician serving Yukon, Oklahoma since 1997, is proud to announce her collaboration with Tekton Research to pioneer advancements in pediatric healthcare.
With a Bachelor’s degree in Biology from Southwestern University and a medical degree from the University of Texas Medical Branch, Dr. Arambula completed her residency at the University of Oklahoma Children’s Hospital, where she served as Chief Resident before establishing her private practice. Her dedication to pediatric care is underscored by a profound appreciation for diversity, cultivated during her upbringing in a military family.
Dr. Arambula’s approach to pediatric medicine is centered on empowering parents and children alike through attentive listening and comprehensive education. She emphasizes the importance of involving children in their healthcare decisions from an early age, fostering trust and empowerment within families.
“The past years have highlighted significant challenges in pediatric medicine. The scarcity of pediatric treatments and the skepticism around new therapies spurred my decision to contribute to solutions. Through clinical trials, we can innovate and advance treatments for children globally.”
Dr. Arambula will focus on clinical trials of therapies in their later stages of development at Tekton Research. These studies assess the effectiveness and safety of treatments that have shown promise in adults but require further validation for pediatric use.
“The safety and efficacy of these therapies have already been rigorously tested before reaching the final stages of development,” Dr. Arambula explained. “Participation in research will not affect the quality of care in our practice. Families may be invited to consider participation based on their child’s needs, with no obligation to participate.”
This partnership represents a significant milestone in pediatric medicine. By combining their expertise and resources, Tekton Research and Dr. Arambula are dedicated to advancing research frontiers and improving healthcare outcomes for young patients in Yukon and beyond.
For further information or to schedule a meeting with Tekton’s Business Development team, please contact feasibility@tektonresearch.flywheelstaging.com.
